The relationships of antithrombin Ⅲ and D-dimer with pediatric critical illness score in children with sepsis QI Yingzheng (Department of Pediatrics, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China)
[1] 胡亚美,江载芳. 诸福棠实用儿科学 [M]. 7版. 北京:人民卫生出版社,2005:2559-2567. [2] O’Brien M. The reciprocal relationship between inflammation and coagulation [J]. Top Companion Anim Med,2012,27(2):46-52. [3] Kinasewitz GT,Yan SB,Basson B,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis,regardless of causative micro-organism [J]. Crit Care,2004,8(2):R82-R90. [4] 中华医学会儿科学会急救组.小儿危重病例评分法(草案)[J]. 中华儿科杂志,1995,33(6):370-373. [5] 中华医学会儿科学分会急救学组,中华医学会急诊学分会儿科组中华儿科杂志编辑委员会. 儿科感染性性休克( 脓毒性休克) 诊疗推荐方案 [J]. 中华儿科杂志,2006,44( 8):596-598. [6] de Laforcade A. Diseases associated with thrombosis [J].Top Companion Anim Med,2012,27 (2):59-64. [7] Dhainaut JF,Shorr AF,Macias WL,et al. Dynamic evolution of coagulopathy in the first day of severe sepsis:relationship with mortality and organ failure [J]. Crit Care Med,2005,33(2):341-348. [8] Afshari A,Wetterslev J,Brok J,et al. Antithrombin Ⅲ in critically ill patients:systematic review with meta-analysis and trial sequential analysis [J]. BMJ,2007,335 (7632):1248-1251. [9] Zeerleder S,Hack CE,Wuillemin WA. Disseminated intravascular coagulation in sepsis [J]. Chest, 2005,128 (4):2864-2875. [10] LaRosa SP,Opal SM. Tissue factor pathway inhibitor and antithrombin trial results [J].Crit Care C1in,2005,21(3) :433-448. [11] 齐云晓,刘敏涓,叶絮. 脓毒症患者血栓前体蛋白测定的临床价值探讨 [J]. 血栓与止血学,2008,14(2):105-107. [12] Hack CE. Fibrfinolysis in disseminated intravascular coagulation [J]. Semin Thromb Hemost,2001,27(6):633-638. [13] 何新飙,闫素英,丁红叶. 血浆内皮素和凝血功能对脓毒症近期预后的判断价值 [J]. 中国危重病急救医学,2009,53(7):633-638. [14] Rodelo JR, De la Rosa G, Valencia ML, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis [J]. Am J Emerg Med,2012,30(9):1991-1999.